(1)
Spectrum of BCR-ABL Mutations and Treatment Outcomes in Imatinib-Resistant CML Patients: A Retrospective Analysis from a Tertiary Centre in South India. JOC 2025, 24 (4), 261-270. https://doi.org/10.64149/J.Carcinog.24.4.261-270.